The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bridgebio Pharma Llc since year 2005.
The trader's CIK number is 1743881.
At the time of this reporting, Bridgebio Pharma Llc is the 10% Owner of Eidos Therapeutics, Inc. .
(stock ticker symbol EIDX).
See this page for all insider trading activities at Eidos Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-10||EIDX||Eidos Therapeutics, Inc.||Sale||40,653||13.62||553,897|
|2018-12-06||EIDX||Eidos Therapeutics, Inc.||Sale||38,970||13.34||519,859|
|2018-12-07||EIDX||Eidos Therapeutics, Inc.||Sale||41,174||14.15||582,612|
|2018-12-05||EIDX||Eidos Therapeutics, Inc.||Buy||1,103,848||14.01||15,464,910|
|2018-12-03||EIDX||Eidos Therapeutics, Inc.||Buy||1,750,000||15.50||27,125,000|
|2018-06-22||EIDX||Eidos Therapeutics, Inc.||Buy||1,000,000||17.00||17,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bridgebio Pharma Llc (10% Owner of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.